Post-market surveillance is the phase of the medical device lifecycle that never ends. Once a device is cleared or approved and reaches patients, a device company assumes ongoing obligations that compound with every complaint, adverse event, and field safety issue that arises. For quality systems teams already stretched thin, the administrative demands of a functioning post-market surveillance program can overwhelm operations.
FDA's 2024 Medical Device Safety Action Plan reinforced the agency's commitment to strengthening post-market surveillance oversight, signaling increased scrutiny of complaint handling systems, MDR reporting timeliness, and field corrective action documentation. Companies with weak administrative systems in their post-market function face mounting inspection risk.
The Four Pillars of Post-Market Surveillance Administration
Complaint Intake Triage Documentation: Every customer complaint received by a medical device company must be evaluated under the company's complaint handling procedure to determine whether it's a reportable MDR event, a CAPA candidate, or a non-reportable service issue. The VA manages the complaint intake log, creates complaint records in the quality management system (QMS), assigns triage categories, and routes records to the appropriate complaint handling owner. High-volume complaint intake—common for Class II devices with a large installed base—can generate dozens of records per week that require timely documentation.
MAUDE Database Monitoring: The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a publicly accessible repository of adverse event reports for all medical devices. Quality and regulatory teams monitor MAUDE for their own devices (to identify trends and reporting gaps), for competitor devices (for benchmarking and market intelligence), and for similar devices (for post-market safety signal detection). The VA conducts structured MAUDE searches on a defined schedule, extracts relevant reports, and prepares MAUDE monitoring summaries for the post-market surveillance team's review.
Field Safety Corrective Action (FSCA) Coordination: When a device defect or safety issue requires a field action—recall, field correction, or safety notice—the coordination burden is enormous. The VA manages the FSCA customer notification list, tracks acknowledgment receipts, logs returned or corrected units, and maintains the field action status dashboard required for FDA inspection.
Customer Complaint Investigation Tracking: FDA regulations require documented investigations for all complaints. The VA tracks open investigations, flags investigations approaching deadline, compiles investigation documentation packages, and prepares the investigation closure summary for quality manager review and signature.
Regulatory Stakes
FDA 21 CFR Part 803 requires MDR reports for device-related deaths within 5 days and other serious injuries within 30 days. FDA's Warning Letter database shows that failures in complaint handling timeliness and MDR reporting are among the most frequent 483 observations issued during device facility inspections. In FY2023, FDA issued over 380 Warning Letters to device companies—many citing complaint handling and MDR deficiencies.
A lapse in post-market surveillance administration isn't just a process failure—it can trigger a consent decree that freezes distribution of the company's entire product line.
The VA Solution
Post-market surveillance VAs with quality systems familiarity can operate within platforms like MasterControl, Veeva Vault Quality, or TrackWise to maintain complaint records, generate investigation reports, and support FSCA coordination. The VA doesn't make MDR reportability determinations—those require regulatory expertise—but handles the documentation and tracking that keeps the complaint system audit-ready.
Build a resilient post-market surveillance operation at Stealth Agents with dedicated VA support that keeps complaint files complete and investigations on schedule.
Sources
- FDA Medical Device Safety Action Plan, 2024
- FDA 21 CFR Part 803 Medical Device Reporting Regulations
- FDA Warning Letter Database, CDRH, FY2023
- FDA MAUDE Database User Guide, Center for Devices and Radiological Health
- FDA 21 CFR Part 820 Quality System Regulation